PENSACOLA, Florida — October 9, 2025 – Lovell® Government Services (Lovell) and DefEYE,
Inc. (DefEYE), an exclusive provider of BIOVANCE® decellularized basement membranes for
ocular use, announced today that they have partnered to serve federal healthcare systems
including the Veterans Health Administration, the Department of Defense Military Health
System, and the Indian Health Service. Lovell will serve as DefEYE’s Service-Disabled Veteran
Owned Small Business (SDVOSB) vendor to serve these customers through federal contracting
systems.
“Lovell Government Services is proud to partner with DefEYE to bring its ophthalmic-biologic
products to federal healthcare providers,” said Chris Lovell, Major, USMC (Ret.), CEO of Lovell
Government Services. “By making DefEYE’s BIOVANCE ocular portfolio available through our
contract vehicles, we streamline practitioner and hospital acquisition, help agencies meet
SDVOSB goals, and most importantly expand access to eye care innovations that help preserve
and restore vision for the veterans we serve.”
DefEYE’s BIOVANCE 3L Ocular and BIOVANCE are the only decellularized basement membranes
used to elevate the management of ocular surface disease and ocular surgery. In particular,
Biovance 3L Ocular possesses a tri-layer architecture with a preserved natural epithelial
basement membrane and intact extracellular matrix structure. The unique design
simultaneously adheres to the ocular surface and facilitates cellular migration supporting
natural ocular surface healing. BIOVANCE products are uniquely available in six shapes and
sizes, all ring-free and bidirectional to provide patient comfort and application flexibility.
Aseptically processed and terminal sterilized, BIOVANCE products are also shelf stable at room
temperature.
“We are proud to partner with Lovell to expand treatment options for military service
members and veterans with our BIOVANCE ocular portfolio of decellularized basement
membranes,” said Rob Sambursky, MD, CEO of DefEYE, Inc. “Ocular surface disease is a
common condition that causes significant discomfort and visual impairment among those who
have served our country. BIOVANCE offers physicians an innovative option for both in-office
and surgical use. By combining a biologic scaffold for cellular migration with active signaling
proteins, our decellularized basement membranes deliver a more effective, clinically
meaningful solution for managing ocular surface disease.”
About DefEYE, Inc.
DefEYE, Inc. is a rapidly growing ocular company on a mission to transform and personalize
therapeutic approaches in eye care. The company focuses on delivering a portfolio of
innovative decellularized biologic solutions that optimize treatment and management of
various eye care conditions, including ocular surface diseases, pterygium surgery, and other
surgical interventions. To learn more, visit www.defeye.com.
About Lovell Government Services
Lovell Government Services has been a trusted Service-Disabled Veteran-Owned Small Business
vendor since 2013 with a proven track record of successfully introducing suppliers to the
government market. Lovell is a four-time Inc. 5000 honoree and leader in the federal space.
They partner with medical and pharmaceutiecal companies looking to better serve Veteran and
military patient populations, increase their federal revenue stream, and win government
contracts. Learn more at www.lovellgov.com
For Media Inquiries:
Lovell:
Jeff McKay
media@lovellgov.com
850-912-4680
DefEYE, Inc:
Amy Phillips
amy.phillips@launchlabpartners.com
412-327-9499
